Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Coloplast Director's Dealing 2019

Aug 27, 2019

3358_rpt_2019-08-27_3d608fe8-f11a-4f92-8c7e-d1a0ceab5dd4.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Trading in Coloplast shares by board members, executives or associated persons

Trading in Coloplast shares by board members, executives or associated persons

Nasdaq Copenhagen

 



27 August 2019
Report on transactions of executives and related parties in Coloplast shares and

related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.

The below transaction concerns the exercise of share options (purchase) and sale of shares.

Calculation of share price:

When calculating the share price in connection with exercise of share options the purchase price is based on the strike price. The strike price is the share price at the grant date. In connection with sales the share price on the time of exercise is used.

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Paul R. Marcun
2 Reason for the notification
a) Position/status Executive Vice President
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Coloplast A/S (CVR-no.: 69749917)
b) LEI 529900NN7SOJ5QG82X67
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Share options
Identification code ISIN: DK0060448595
b) Nature of the transaction Exercise of share options (purchase)
c) Price(s) and volume(s) Price(s) Volumes(s)
482.67 12,282
d) Aggregated information
-  Aggregated volume 12,282 shares
-  Price DKK 482.67
e) Date of the transaction 2019-08-23, 09:12 UTC
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Paul R. Marcun
2 Reason for the notification
a) Position/status Executive Vice President
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Coloplast A/S (CVR-no.: 69749917)
b) LEI 529900NN7SOJ5QG82X67
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument B shares
Identification code ISIN: DK0060448595
b) Nature of the transaction Sale of shares
c) Price(s) and volume(s) Price(s) Volumes(s)
810.75 12,282
d) Aggregated information
-  Aggregated volume 12,282 shares
-  Price 810.75 DKK
e) Date of the transaction 2019-08-26, 15:00 UTC
f) Place of the transaction Outside a trading venue

Attachment